Tonira Pharma Ltd.,(Since amalgamated with IPCA Lab. Ltd.), Baroda V. The ACIT, Circle-4, Baroda

ITA 2042/AHD/2014

• Counselvise Citation: [2019] 116 COUNSELVISE.COM (IT) 7284 (ITAT-AHMEDABAD)
• Duration Of Justice: 5 year(s) 21 day(s)
• Appeal Type: Income Tax Appeal
• Pronouncement Date: 29-07-2019
• Appeal Filed By: Assessee
• Order Result: Partly Allowed
• Bench Allotted: D
• Assessment Year: 2010-2011
• Appeal Filed On: 08-07-2014
• Result in Favour of: Partly Allowed
• Court: TRIBUNAL
• Department Lawyers: RAJESH MEENA
• Assessee Lawyers: S N SOPARKAR
• Keywords: Capital asset; Depreciation; Earning of tax free income; Bad and doubtful debts; Competent authority
• Section: 143(3); 14A; 6; 28

Judgement Text

, D IN THE INCOME TAX APPELLATE TRIBUNAL D BENCH, AHMEDABAD BEFORE SHRI RAJPAL YADAV, JUDICIAL MEMBER & SHRI PRADIP KUMAR KEDIA, ACCOUNTANT MEMBER . / I.T.A. NO. 2042/AHD/2014 ( ASSESSMENT YEAR : 2010-11) TONIRA PHARMA LTD. (SINCE AMALGAMATED WITH IPCA LAB. LTD.) 301, YOGI COMPLEX, SAMPATRAO COLONY, ALKAPURI, BARODA - 390007 / VS. ACIT CIRCLE - 4, BARODA ./ ./ PAN/GIR NO. : AABCT0638F ( APPELLANT ) .. ( / RESPONDENT ) / APPELLANT BY : SHRI S. N. SOPARKAR & SHRI PARIN SHAH, A.R. / RESPONDENT BY : SHRI RAJESH MEENA, SR.D.R. DATE OF HEARING 27/06/2019 !'# / DATE OF PRONOUNCEMENT 29/07/2019 / O R D E R PER PRADIP KUMAR KEDIA - AM: THE CAPTIONED APPEAL HAS BEEN FILED AT THE INSTANCE OF THE ASSESSEE AGAINST THE ORDER OF THE COMMISSIONER OF INCOME TAX (APPEALS)-III, BARODA (CIT(A) IN SHORT), DATED 15.05.2014 ARISING IN TH E ASSESSMENT ORDER DATED 26.03.2013 PASSED BY THE ASSESSING OFFICER (AO) UND ER S. 143(3) OF THE INCOME TAX ACT, 1961 (THE ACT) CONCERNING AY 2010-1 1. ITA NO. 2042/AHD/14 [TONIRA PHARMA. LTD. VS. ACIT] A.Y. 2010-11 - 2 - 2. THE GROUNDS OF APPEAL RAISED BY ASSESSEE READ AS UNDER: 1 LD. CIT (A) ERRED IN LAW AND ON FACTS IN CONFIRM ING ACTION OF AO IN REJECTING WRITE OFF OF OBSOLETE INVENTORY TO THE EX TENT OF RS. 1,00,68,057/-BY THE APPELLANT. LD. CIT (A) OUGHT TO HAVE DELETED DISALLOWANCE HOLDING WRITE OFF OF OBSOLETE STOCK HA VING NIL REALIZABLE VALUE IN ACCORDANCE WITH ACCOUNTING PRIN CIPLES IS AN ALLOWABLE DEDUCTION. IT BE SO HELD NOW. 2 BOTH THE LOWER AUTHORITIES ERRED IN LAW AND ON F ACTS IN NOT APPRECIATING THE FACT THAT OBSOLETE PHARMACEUTICAL PRODUCTS HAZARDOUS FOR HUMAN LIVES WERE REQUIRED TO BE DESTR OYED BY APPELLANT UNDER NORMS OF THE PHARMA INDUSTRY. LD. C IT (A) OUGHT TO HAVE ACCEPTED WRITE OFF OF MATERIAL DUE TO ITS EXPI RY AND NON USABILITY BY DELETING DISALLOWANCE MADE BY AO. IT B E SO HELD NOW. 3 ALTERNATIVELY AND WITHOUT PREJUDICE TO THE ABOVE CONTENTION, THE APPELLANT OUGHT TO BE ALLOWED THE WRITING OFF OF RA W MATERIALS BECOMING OBSOLETE AS BUSINESS LOSS U/S 28 OF THE AC T. LD. CIT (A) OUGHT TO HAVE ALLOWED GENUINE BUSINESS LOSS SUFFERE D BY APPELLANT ON WRITING OFF OF STOCK FOUND OBSOLETE ON DETECTION DURING THE YEAR UNDER CONSIDERATION. IT BE SO HELD NOW. 4 LD. CIT (A) ERRED IN LAW AND ON FACTS IN CONFIRM ING ADHOC DISALLOWANCE OF INTEREST EXPENSES ESTIMATING 10% OF WIP VALUE U/S 36(1)(III) OF THE ACT. LD. CIT (A) FURTHER ERRED IN LAW AND ON FACTS IN DIRECTING AO TO ALLOW DEPRECIATION ON CAPITALIZE D INTEREST IN THE YEAR IN WHICH CAPITAL ASSET IS PUT TO USE. LD. CIT (A) OUGHT TO HAVE ALLOWED DEPRECIATION DURING THE YEAR. 5 LD. CIT (A) ERRED IN LAW AND ON FACTS IN CON FIRMING DISALLOWANCE BY AO ON ACCOUNT OF BAD DEBTS OF RS. 2,68,465/- WRITTE N OFF IN RESPECT OF EXCISE DUTY REFUND. LD. CIT (A) OUGHT TO HAVE DE LETED DISALLOWANCE. IT BE SO HELD NOW. 6 LD. CIT (A) ERRED IN LAW AND ON FACTS IN RESTR ICTING DISALLOWANCE MADE BY AO TO RS. 19,216/- FOR EARNING EXEMPT INCOM E OF RS. 1134/- U/S 14A OF THE ACT. LD. CIT (A) OUGHT TO HAV E DELETED DISALLOWANCE IN ABSENCE OF ANY EXPENSES INCURRED BY THE APPELLANT TO EARN EXEMPT INCOME. 7 LD. CIT (A) ERRED IN LAW AND ON FACTS IN CONFIR MING ACTION OF AO MAKING ADJUSTMENT IN BOOK PROFIT BY AMOUNT OF ADDIT ION MADE U/S 14A OF THE ACT. LD. CIT (A) OUGHT TO HAVE DELETED S UCH ADJUSTMENT NOT PERMISSIBLE UNDER LAW. IT BE SO HELD NOW. 3. GROUND NOS. 1 TO 3 CONCERN LOSS ARISING FROM WRI TE OFF OF INVENTORY TO THE EXTENT OF RS.1,00,68,057/- CLAIMED TO BE OBS OLETE AND NON-USABLE BY THE ASSESSEE COMPANY. ITA NO. 2042/AHD/14 [TONIRA PHARMA. LTD. VS. ACIT] A.Y. 2010-11 - 3 - 4. BRIEFLY STATED, THE ASSESSEE IS ENGAGED IN THE B USINESS OF MANUFACTURING OF BULK DRUGS, INTERMEDIATES AND FINE CHEMICALS. IN THE COURSE OF ASSESSMENT PROCEEDINGS, THE AO NOTED SUBS TANTIAL FALL IN THE GROSS PROFIT RATIO DECLARED BY THE ASSESSEE VIS--V IS EARLIER YEARS. ON FURTHER INQUIRY, IT WAS NOTICED BY THE AO THAT THE ASSESSEE HAS REDUCED ITS CLOSING STOCK BY SUM OF RS.1,00,68,057/-. IT WAS E XPLAINED ON BEHALF OF THE ASSESSEE THAT LOWERING OF CLOSING STOCK IS ON ACCOU NT OF WRITE OFF OF VALUE OF CERTAIN MATERIALS BECAUSE OF ITS EXPIRY OR TECHN ICAL NON-USABILITY AS ADVISED BY PLANT MANAGERS. THE SUMMARY OF NON-MOVI NG STOCK FOR WRITE OFF AS FURNISHED TO THE AO IS REPRODUCED HEREUNDER: PARTICULARS ANKLESHWAR NANDESARI TOTAL RAW MATERIAL 1780778.88 946574.51 2727353.39 W.I.P. 171044.20 5653439.29 5824483.49 FINISHED GOODS 1516219.83 O.OO 1516219.83 TOTAL 3468042.91 6600013.80 10068056.71 5. THE AO HOWEVER OBSERVED THAT THE ASSESSEE HAS FA ILED TO FURNISH THE SUPPORTIVE EVIDENCES, SUCH AS, CERTIFICATE FROM NAR COTICS AND EXCISE AUTHORITIES OR SOME OTHER COMPETENT AUTHORITIES. T HE DOCUMENTARY EVIDENCES SHOWING EXPIRY DATE OF MATERIAL UNDER WRI TE OFF WAS ALSO NOT FURNISHED. THE AO ALSO NOTICED THAT SOME LETTERS A DDRESSED TO EXCISE AUTHORITIES WERE SUBMITTED WHERE THE ASSESSEE HAS M ADE A REQUEST TO THE AUTHORITIES TO DESTROY THE RAW MATERIALS OF RS.4,61 ,078/- WHICH LETTER ALSO RELATES TO FY 2012-13 AND THEREFORE, IT IS DIFFICUL T TO ASCERTAIN WHETHER THE DESTRUCTION WAS OF THE MATERIAL RELATABLE TO FY 09- 10 CONCERNING AY 2010- 11 OR OTHER PERIOD. THE AO FURTHER NOTED THAT INVE NTORY WAS VALUED AT FULL COST TILL LAST YEAR WITHOUT ANY WRITE OFF AND THERE FORE IT WAS FOR THE ASSESSEE TO SHOW THAT THE MATERIAL HAS TURNED OBSOLETE AND R ENDERED UNUSABLE DURING THE FY 2009-10 IN QUESTION. IN THE ABSENCE OF ANY TECHNICAL REPORT OR CERTIFICATE FROM COMPETENT AUTHORITIES FOR IDENTIFI CATION OF NON-MOVING ITEMS OR OBSOLETE ITEMS, THE AO REJECTED THE CLAIM OF LOSS MADE BY THE ASSESSEE AND CONSEQUENT LOWERING OF CLOSING STOCK O WING TO SUCH OBSOLETION. THE TAXABLE INCOME WAS CONSEQUENTLY IN CREASED TO THE EXTENT OF RS.1,00,68,057/-. ITA NO. 2042/AHD/14 [TONIRA PHARMA. LTD. VS. ACIT] A.Y. 2010-11 - 4 - 6. AGGRIEVED, THE ASSESSEE PREFERRED APPEAL BEFORE THE CIT(A). 7. THE CIT(A) RE-VISITED THE SUBMISSIONS MADE ON BE HALF OF THE ASSESSEE AS REPRODUCED IN PARA 4.2 OF ITS ORDER BUT FOUND LITTLE MERIT IN THE CLAIM OF LOSS RESULTING FROM WRITE OFF OF VALUE OF INVENTORY. THE CONCLUSION DRAWN BY THE CIT(A) ON THE ISSUE IS REPR ODUCED HEREUNDER FOR READY REFERENCE: 4.3. I HAVE CONSIDERED THE FACTS OF THE CASE, THE SUBMISSION MADE BY THE APPELLANT AND THE AO'S OBSERVATIONS. A PERUSAL OF T HE AUDIT REPORT IN FORM NO. 3CD SHOWS THAT DURING THE PREVIOUS YEAR 20 09-10, THE APPELLANT HAD VALUED THE CLOSING STOCK AT COST OR AT NET REAL IZABLE VALUE WHICHEVER IS LOWER, WORK IN PROGRESS WAS VALUED AT ESTIMATED COST AND RAW MATERIAL AND OTHER STOCK WERE VALUED AT COST. THUS, THIS IS NOT A CASE WHERE THE APPELLANT WAS VALUING THE RAW MATERIAL AT COST OR N ET REALIZABLE VALUE WHICHEVER IS LOWER. HENCE, THE RELIANCE PLACED BY T HE APPELLANT ON THE DECISION IN THE CASE OF SONIC BIOCHEM EXTRACTIONS P VT. LTD. 59 SOT 4 (MUM) IS NOT APPLICABLE. FURTHER, IN THE DECISIONS RELIED UPON BY THE APPELLANT IN THE CASE OF EMERSONS PROCESS MANAGEMEN T INDIA PVT. LTD. 45 SOT 157 (MUM) AND BHARAT HEAVY ELECTRICALS LTD. 98 TTJ (DEL) 565, FINDINGS HAVE BEEN GIVEN THAT THERE WERE MECHANISM FOR IDENTIFYING SUCH STOCK: IN ONE CASE A SPECIAL COMMITTEE HAD RECOMMEN DED THE WRITE OFF AND IN OTHER CASE THERE WAS AUDITOR VERIFICATION FOR TH E FACT THAT THE STOCKS HAD BECOME NON MOVING OR OBSOLETE. IN THE PRESENT C ASE THERE IS NO SUCH MECHANISM INVOLVED. INFACT, THE AUDITOR'S REPORT AS WELL AS THE AUDITED ACCOUNTS OF THE APPELLANT ARE TOTALLY SILENT IN THI S REGARD. NOWHERE IT HAS BEEN MENTIONED BY THE AUDITOR, EITHER IN AUDIT REPO RT OR IN THE AUDITED ACCOUNTS THAT CERTAIN PARTS OF RAW MATERIALS AND FI NISHED GOODS 'HAD BEEN TREATED AS OBSOLETE AND HAD BEEN VALUED AT NIL AMOU NT. EVEN WHEN THE AO ASKED THE APPELLANT TO PROVIDE THE REASON FOR THE D OWNFALL IN GROSS PROFIT AS COMPARED TO THE EARLIER YEAR, IN THE FIRST SUBMI SSION THE APPELLANT DID NOT REFER TO ANY SUCH STOCK WORTH 1,00,68,057/- HAVING NIL VALUE. IT WAS ONLY IN THE SECOND SUBMISSION THAT THE APPELLANT CL AIMED SO, EVEN, DURING THE COURSE OF APPELLATE PROCEEDINGS, THE APPELLANT HAS ONLY SUBMITTED THE LIST OF SUCH ITEMS AND HAVE NOT EXPLAINED THE SCIEN TIFIC BASIS FOR VALUATION OF SUCH STOCK AT NIL. THE ONLY EVIDENCE SUBMITTED I S REGARDING THE DESTRUCTION OF THE SMALL PART OF SUCH STOCK AFTER T AKING APPROVAL FROM NARCOTICS CONTROL BUREAU OF INDIA. THIS HAS ALSO NO T HAPPENED DURING THE FY 2009-10 BUT IN SUBSEQUENT YEAR. THUS, THE APPELL ANT HAS NOT PRODUCED ANY EVIDENCE TO SUBSTANTIATE ITS CLAIM THAT THE VAL UE OF SUCH CLOSING STOCK HAD BECOME NIL DURING THE FY 2009-10 ITSELF. IT MAY BE MENTIONED THAT MAJORITY PART OF SUCH STOCK IS RAW MATERIAL WHICH W AS BEING VALUED AT COST BY THE APPELLANT. UNDER SUCH CIRCUMSTANCES, THE VAL UATION OF SUCH STOCK AT NIL MEANS THAT THE APPELLANT IS CLAIMING BUSINESS L OSS U/S 28 OF THE IT ACT, 1961 ON ACCOUNT OF SUCH ACTION. UNDER SUCH CIRCUMST ANCES, THE APPELLANT HAS TO ESTABLISH THAT THE VALUE OF SUCH STOCK BECOM E NIL IN THE YEAR IN WHICH THESE WERE VALUED AT NIL AMOUNT AND NOT IN AN Y PRECEDING YEAR OR SUBSEQUENT YEAR. THIS IS, AS PER THE RATIO LAID DOW N BY THE HON'BLE SUPREME COURT OF INDIA IN THE CASE OF GLASS MINIATU RE BULB INDUSTRIES 204 ITR 352 (SC), HENCE, THE CLAIM OF THE APPELLANT IS NOT ALLOWABLE. ITA NO. 2042/AHD/14 [TONIRA PHARMA. LTD. VS. ACIT] A.Y. 2010-11 - 5 - ACCORDINGLY, THE AO'S ACTION OF MAKING DISALLOWANCE OF THIS AMOUNT IS UPHELD AND THIS GROUND OF APPEAL IS DISMISSED. 8. AGGRIEVED BY THE ENDORSEMENT OF THE ACTION OF TH E AO BY THE CIT(A), THE ASSESSEE PREFERRED APPEAL BEFORE THE TRIBUNAL. 9. THE LEARNED AR FOR THE ASSESSEE BROADLY REITERAT ED VARIOUS SUBMISSIONS MADE BEFORE THE LOWER AUTHORITIES. IT WAS CONTENDED THAT MATERIAL USED IN PHARMACEUTICAL INDUSTRY ARE TYPICA L AND IS RENDERED UNUSABLE WITH THE EFFLUX OF TIME. THE LOSS ARISING FROM OBSOLETION OF MATERIAL IS A NORMAL INCIDENCE OF THE BUSINESS OF T HE ASSESSEE. THE LEARNED AR SUBMITTED THAT THE LOSS TOWARDS OBSOLETE STOCK C ARRYING NO VALUE HAS BEEN CLAIMED BY THE ASSESSEE IN ACCORDANCE WITH GEN ERALLY ACCEPTED ACCOUNTING PRACTICES AND POLICIES IN INDIA AND THER EFORE, THERE WAS NO WARRANT FOR THE REVENUE AUTHORITIES TO REJECT THE S AME IN WHOLESALE. THE LEARNED AR REFERRED TO THE DETAILS OF NON-MOVING ST OCK FOR WRITE OFF AT PAGE NOS. 8 TO 13 OF ITS PAPER BOOK AND CONTENDED THAT T HE OBJECTIVE DETAILS WERE PROVIDED TO THE AO WHILE INDULGING IN SUCH WRITE OF F. HOWEVER, ON A QUERY FROM THE BENCH REGARDING DETAILS OF SIMILAR WRITE O FF IN THE EARLIER YEARS, THE LEARNED AR DID NOT OFFER ANY COMMENTS. THE LEA RNED AR, HOWEVER, IN THE SAME VAIN, INSISTED THAT THE CLAIM MADE BY THE ASSESSEE TOWARDS SUCH WRITE OFF IS ALSO SUPPORTABLE BY SOME OF THE CORRES PONDENCES WITH THE REGULATORY AUTHORITIES. THE LEARNED AR ALSO PLACED ON RECORD JUDICIAL PRECEDENTS AND SUBMITTED THAT THE VERSION OF THE AS SESSEE REQUIRES TO BE ACCEPTED UNLESS THERE ARE STRONG REASONS TO DISBELI EVE SUCH VERSION. IT WAS THUS URGED THAT THE BONAFIDE CLAIM OF LOSS MADE BY THE ASSESSEE TOWARDS WRITE OFF OF CLOSING INVENTORY CANNOT BE SHRUGGED A ND DISCREDITED IN A SUMMARY MANNER. 10. THE LEARNED DR, ON THE OTHER HAND, RELIED UPON THE ORDERS OF THE AO AND CIT(A). IT WAS FURTHER SUBMITTED THAT THE ONUS WAS ON THE ASSESSEE TO PROVIDE THE DOCUMENTARY EVIDENCES AND DETAILS FOR C LAIMING WRITE OFF OF SUCH HUGE AMOUNT AGAINST A MEAGER BOOK PROFIT OF RS .1.34 CRORES AND A CLOSING INVENTORY OF RS.11.73 CRORES. IT WAS SUBMI TTED THAT WRITE OFF OF ITA NO. 2042/AHD/14 [TONIRA PHARMA. LTD. VS. ACIT] A.Y. 2010-11 - 6 - NEARLY RS.1 CRORE OF SUCH CLOSING STOCK IS VERY HIG H AND IS NOT COMMENSURATE IN THE CONTEXT OF THE CASE AND THE PRO FIT DECLARED OF RS.1.34 CRORE WOULD ALSO INDICATE LACK OF JUSTIFICATION OF SUCH HUGE OBSOLETION OCCURRED IN THE BUSINESS. THE LEARNED DR ACCORDING LY SUBMITTED THAT NO INTERFERENCE WITH THE ORDER OF THE CIT(A) IS CALLED FOR. 11. WE HAVE CAREFULLY CONSIDERED THE RIVAL SUBMISSI ONS AND PERUSED THE MATERIAL REFERRED TO AND RELIED UPON IN TERMS OF RU LE 18(6) OF ITAT RULES AND CASE LAWS CITED. THE ESSENTIAL QUESTION BEFORE THE TRIBUNAL IS WHETHER THE REVENUE AUTHORITIES WERE JUSTIFIED IN DENYING T HE CLAIM OF RS.1,00,68,057/- AS LOSS TOWARDS OBSOLETE AND NON-U SABLE STOCK. 11.1 AS NOTICED FROM THE FACTS NARRATED IN EARLIER PARAS, THE ASSESSEE HAS CLAIMED LOSS TOWARDS WRITE OFF OF OBSOLETE AND NON- MOVING STOCK TO THE TUNE OF RS.1,00,68,057/-. THE ASSESSEE HAS EXPLAIN ED THAT THE WRITE OFF IS MAINLY ON ACCOUNT OF OBSOLETE ITEMS IDENTIFIED BY T HE ASSESSEE TO BE NOM- MOVING AND UNUSABLE AND HAVING REGARD TO THE TYPICA L CHARACTER OF PHARMA COMPANIES. ACCORDINGLY, THE ASSESSEE HAS REDUCED T HE VALUE OF CLOSING STOCK TOWARDS OBSOLETE MATERIAL RECOGNIZED BY IT. THE AO HELD THAT THE ASSESSEE HAS NEITHER FURNISHED THE SUPPORTIVE DOCUM ENTS FOR CLAIMING SUCH LOSS ON ACCOUNT OF OBSOLETE ITEMS NOR PRODUCED ANY RECORD TO SHOW THAT ITEMS WERE NOT MOVING. THE AO ACCORDINGLY DENIED T HE LOSS CLAIMED ON ACCOUNT OF SUCH OBSOLETION. 11.2 WE PAUSE HERE TO NOTE THAT THERE CAN BE NO DIS PUTE THAT THE ASSESSEE IS ENTITLED TO VALUE THE CLOSING STOCK AT MARKET VA LUE OR AT COST WHICHEVER IS LOWER IN TUNE OF RECOGNIZED ACCOUNTING POLICIES. H OWEVER, THE QUESTION ARISES AS TO WHETHER THE ACTION OF THE ASSESSEE IN DECLARING A LIST OF CERTAIN ITEMS TO BE UNFIT AND NON-USABLE FOR THE PURPOSE OF ITS ONGOING BUSINESS IS JUSTIFIED AND SUPPORTABLE. IN THIS CONTEXT, WHILE W E NOTE THAT HAVING REGARD TO THE SPECIAL NATURE OF MATERIAL CLAIMED TO BE USE D IN PHARMACEUTICAL INDUSTRIES WHICH ARE OF SENSITIVE NATURE, SOME OBSE LETION MAY ARISE ON A REGULAR BASIS. IT IS THE BOUNDEN DUTY OF THE MANAG EMENT TO ELIMINATE SUCH OBSOLETE STOCK FROM THE PROCESS. ITA NO. 2042/AHD/14 [TONIRA PHARMA. LTD. VS. ACIT] A.Y. 2010-11 - 7 - 11.3 KEEPING THIS NARRATIVE IN THE MIND, WE HOWEVER NOTE THAT THE ASSESSEE HAS TOTALLY FAILED TO PROVIDE ANY JUSTIFICATION FOR QUANTIFICATION OF OBSOLETE STOCK. AS NOTICED FROM THE LIST OF SLOW MOVING STO CK AS IDENTIFIED BY THE ASSESSEE, SOME ITEMS CODE IS MENTIONED AGAINST TH E MATERIAL. THEREFORE, THE SPECIFIC RAW MATERIAL AND FINISHED GOODS ARE OB JECTIVELY IDENTIFIABLE. IT SHOULD NOT BE DIFFICULT FOR THE ASSESSEE AT LEAST P ROVIDE BASIS FOR HOLDING THE STOCK TO BE OBSOLETE ON TEST CHECK BASIS. NO P ROOF OF DESTRUCTION OF SUCH OBSOLETE STOCK IN THE FORM OF CERTIFICATION OF COMPETENT AUTHORITY VIZ. CENTRAL EXCISE, NARCOTICS ETC. IS AVAILABLE. IT IS ALSO SEEN FROM THE AUDITED ANNUAL ACCOUNTS OF THE EARLIER FINANCIAL YEAR CONCE RNING FY 2008-09 ( PARA 2 OF THE ANNEXURE TO THE AUDIT REPORT) THAT THE INV ENTORIES WERE ADMITTEDLY VERIFIED PHYSICALLY BY THE MANAGEMENT FOR THE YEAR ENDING MARCH 2009 WHICH REPRESENTS THE OPENING STOCK OF THIS YEAR. W E DO NOT FIND ANYTHING ON RECORD TO SUGGEST THAT ANY OBSOLETE STOCK WAS SU RFACED IN THE PRECEDING YEAR AND LOSS TOWARDS SUCH OBSOLETE ITEMS WERE RECO GNIZED IN THE EARLIER YEAR. NO REAL TIME CORRESPONDENCE HAS BEEN BROUGHT ON RECORD (WHICH IS AN ORDINARY FEATURE OF E-GOVERNANCE OF CORPORATES THES E DAYS) TO SUGGEST CREATION OF NON-MOVING AND OBSOLETE STOCK OF SUCH M AGNITUDE WHICH REPRESENTS NEARLY 10% OF THE TOTAL INVENTORY. PRIM A FACIE, THE ONUS IS ON THE ASSESSEE TO ESTABLISH THAT THE STOCKS OF STAGGE RING AMOUNT HAVE LOST ITS USABLE VALUE. THE ISSUE IS FACTUAL AND WHILE THERE CAN BE NO DENIAL THAT ASSESSEE IS ENTITLED TO CLAIM LOSS TOWARDS OBSOLETE STOCK IN A GIVEN YEAR, IT IS ALSO THE CORRESPONDING DUTY OF THE ASSESSEE TO P ROVE THE EXISTENCE OF SUCH OBSOLETE MATERIAL BY DIRECT OR CIRCUMSTANTIAL EVIDENCES. THE ASSESSEE HAS TOTALLY FAILED IN ITS CORRESPONDING DUTIES. TH E AUDITOR IN THE INSTANT CASE WHILE STATING THAT, INVENTORIES HAVE BEEN PHYSICAL VERIFIED BY THE MANAGEMENT, HAVE NOT POINTED OUT SUCH LARGE SCALE R ECOGNITION OF OBSOLETE ITEM. 11.4 ON CONSPECTUS OF FACTS NOTED ABOVE, WE FIND IT DIFFICULT TO ENTERTAIN THE CLAIM OF THE ASSESSEE IN ENTIRETY WHEN TESTED O N THE TOUCHSTONE OF EVIDENCES IN THIS REGARD. HOWEVER, KEEPING IN MIND THE NARRATIVE OF THE ASSESSEE AND DIFFICULTY POSED IN FURNISHING OBJECTI VE JUSTIFICATION OF MANY ITEMS IN PRACTICE, WE CONSIDER IT APPROPRIATE TO AS SUME LOSS ON ACCOUNT OF ITA NO. 2042/AHD/14 [TONIRA PHARMA. LTD. VS. ACIT] A.Y. 2010-11 - 8 - OBSOLETE ITEM AT 5% OF THE CLOSING STOCK TO BE FAIR AND PLAUSIBLE WHICH WORKS OUT TO RS.58,65,680/-. THE ASSESSEE THUS GET S RELIEF TO THIS EXTENT. IT SHALL BE OPEN TO THE ASSESSEE TO MAKE AMENDS IN THE OPENING STOCK OF SUBSEQUENT FINANCIAL YEAR IN ACCORDANCE WITH LAW. W HILE HOLDING SO, WE ARE NOT INCLINED TO DISCUSS VARIOUS CASE LAWS CITED ON BEHALF OF THE ASSESSEE WHICH ARE RENDERED IN TOTALLY DIFFERENT FACTS. 12. CONSEQUENTLY, GRIEVANCE OF THE ASSESSEE IS PART LY ACCEPTED. 13. GROUND NOS. 1 TO 3 ARE THUS PARTLY ALLOWED. 14. GROUND NO. 4 CONCERNS DISALLOWANCE OF INTEREST EXPENSES UNDER S.36(1)(III) OF THE ACT AMOUNTING TO RS.5,43,456/-. 14.1 THE LEARNED AR FOR THE ASSESSEE FAIRLY SUBMITT ED THAT OWING TO THE SMALLNESS OF THE AMOUNT, IT DOES NOT SEEK TO PRESS THE GRIEVANCE. 14.2 GROUND NO.4 OF THE ASSESSEES APPEAL IS DISMIS SED. 15. GROUND NO.5 CONCERNS DISALLOWANCE OF BAD DEBT W RITTEN OFF AMOUNTING TO RS.2,68,465/- IN RESPECT OF EXCISE DUT Y REFUND. WITH THE ASSISTANCE OF THE LEARNED AR FOR THE ASSESSEE, WE F IND MERIT IN THE CLAIM OF THE ASSESSEE. THE EXCISE DUTY RECEIVED AS REFUND N ATURALLY FORMS PART OF THE REVENUE OPERATIONS OF THE ASSESSEE. THE VERSIO N OF THE ASSESSEE HAS BEEN CONFIRMED BY THE AUDITORS REQUIRES TO BE ORDIN ARILY BELIEVED. THE ACTION OF THE REVENUE AUTHORITIES ARE ACCORDINGLY R EVERSED. 16. GROUND NO. 5 OF THE ASSESSEE IS ACCORDINGLY ALL OWED. 17. GROUND NO.6 CONCERNS DISALLOWANCE OF RS.19,216/ - UNDER S.14A OF THE ACT. IN THE LIGHT OF THE FACT THAT THE EXEMPT INCOME STANDS AT RS.1134/-, DISALLOWANCE IS RESTRICTED TO THE AFORESAID AMOUNT IN VIEW OF THE DECISION OF THE HONBLE DELHI HIGH COURT IN JOINT INVESTMENT 372 ITR 694 (DEL). ITA NO. 2042/AHD/14 [TONIRA PHARMA. LTD. VS. ACIT] A.Y. 2010-11 - 9 - 18. GROUND NO.6 OF THE ASSESSEES APPEAL IS ACCORDI NGLY PARTLY ALLOWED. 19. GROUND NO.7 CONCERNS ADJUSTMENT TO THE BOOK PRO FIT TOWARDS DISALLOWANCE MADE UNDER S.14A OF THE ACT. 20. IN VIEW OF THE DECISION OF THE SPECIAL BENCH IN ACIT VS. VIREET INVESTMENTS LTD. 165 ITD 27 (SB) AND HAVING REGARD TO CLAUSE (F) TO EXPLANATION BELOW 115JB, THE ADJUSTMENT TO THE BOOK S PROFIT IS RESTRICTED TO THE EXTENT OF RS.1134/- ONLY. 21. GROUND NO.7 IS ACCORDINGLY PARTLY ALLOWED. 22. IN THE RESULT, THE APPEAL OF THE ASSESSEE IS PA RTLY ALLOWED. SD/- SD/- (RAJPAL YADAV) (PRADIP KUMAR KEDIA) JUDICIAL MEMBER ACCOUNTANT MEMBER AHMEDABAD: DATED 29/07/2019 TRUE COPY S. K. SINHA !'#' / COPY OF ORDER FORWARDED TO:- &. / REVENUE 2. / ASSESSEE 3. )*+ , / CONCERNED CIT 4. ,- / CIT (A) /. 012 33*+4 *+#4 56) / DR, ITAT, AHMEDABAD 7. 289 : / GUARD FILE. BY ORDER / 4 /5 *+#4 56) THIS ORDER PRONOUNCED IN OPEN COURT ON 29/07/2019